\
&
Contact us
\
&
Contact us
Published on | 5 months ago
Programmes Digital, Industry & Space HPC AI, data & cloudThe EuroHPC Joint Undertaking (EuroHPC JU) has launched two calls for expressions of interest to select hosting entities that will host and operate AI-optimised supercomputers, AI experimental platforms and AI factories across Europe, to be funded under the Digital Europe programme.
EuroHPC will deploy AI-dedicated supercomputing and service infrastructures to support the further development of a highly competitive and innovative AI Ecosystem in the European Union.
The AI Factories initiative seeks to establish a number of comprehensive one-stop shops for AI users, including start-ups, small and medium-sized enterprises (SMEs), and scientific researchers. They will provide streamlined access to a wide range of AI services, including essential tools, skills development, and user support. The aim of AI factories is to provide the European scientific community at large with enhanced access to AI optimised computing capabilities for the large-scale training and development of general-purpose AI models, and for the development, validation and running of emerging AI applications.
The two calls for expressions of interest are each tailored to different types of hosting entities:
Both calls have multiple cut-off dates and will remain open until the final deadline on 31 December 2025. The first cut-off deadline for applications is 4 November 2024.
More information on the two calls can be found in the EuroHPC press release.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Culture and society Agro-Food, Environment Missions
The TIDAL ArtS project is funded under the Mission for clean oceans and inland waters and combines the power of art and science to inspire action for our ocean and waters. In april they will publish a Lighthouse call for proposals of up to 15.000 euro per artistic work. The aim of the project is notably to create public art and raise awareness on... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
